Quick Takeaways
- Julianne Bruno has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $3,717,005.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Julianne Bruno
- Location
- Boston, MA
- Summary
- The estimated net worth of Julianne Bruno is at least $3,717,005 dollars as of 25 Mar 2026. Julianne Bruno is the Director of Damora Therapeutics, Inc. and owns shares of Damora Therapeutics, Inc. (DMRA) stock worth about $2.99M. Julianne Bruno is the Chief Operating Officer of CRISPR Therapeutics AG and owns shares of CRISPR Therapeutics AG (CRSP) stock worth about $727K.
- Signature
- /s/ Garrett Winslow, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Julianne Bruno and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Damora Therapeutics, Inc. ($2,990,038).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Julianne Bruno
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| DMRA | Damora Therapeutics, Inc. | Director | $2,990,038 | 23 Mar 2026 | ||
| CRSP | CRISPR Therapeutics AG | Chief Operating Officer | $726,967 | 20 Mar 2025 |
Insider Transactions Reported by Julianne Bruno:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.